ArticleCardio-oncology (London, England)2019

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series.

Sarju Ganatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.